Yahoo Finance 
Yahoo Finance Plus U.S. trade deficit climbs to record $948.1 billion in 2022
The U.S. trade deficit in 2022 rose to an all-time high for the third year in a row, largely because of higher oil prices and an appetite for consumer goods.
The U.S. trade deficit in 2022 rose to an all-time high for the third year in a row, largely because of higher oil prices and an appetite for consumer goods.
Disney might be the happiest place on earth, but one thing's for sure -- it isn't so happy there today. CEO Bob Iger sent out an email to Disney employees on March 27 informing them that the layoffs previously announced in February have begin.
This futuristic pickup truck developed by Tesla is undoubtedly the most anticipated vehicle of the last decade. No vehicle had generated so much excitement, fueled in part by thundering statements from Elon Musk, CEO of Tesla, and other top executives. Internet searches related to the Cybertruck are considerable.
Short sellers are getting bold again. And they've picked their favorite stock market targets to crash.
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) shares fell almost 20% after Scorpion Capital filed a Citizen's Petition with the FDA requesting the withdrawal of approval of Wakix (pitolisant). When Benzinga reached out to learn more, Harmony Biosciences Spokesperson exclusively told Benzinga, "We are aware of this report from an activist investor and disagree with their assertions. We remain committed to helping those who live with devasting rare diseases, and our science has been subject to p
(Bloomberg) -- On the surface, Charles Schwab Corp. being swept up in the worst US banking crisis since 2008 makes little sense.Most Read from BloombergFBI Releases Files on Ivana TrumpSchwab’s $7 Trillion Empire Built on Low Rates Is Showing CracksBinance and Its CEO Sued by CFTC Over US Regulatory ViolationsSaudi National Bank Chair Resigns After Credit Suisse RemarkThe firm, a half-century mainstay in the brokerage industry, isn’t overexposed to crypto like Silvergate Capital and Signature Ba
Investment is down, labor is scarce, budget is squeezed. Oligarch: ‘There will be no money next year’
Read this before you trade in your gas guzzler.
Aiden Pleterski led a lavish lifestyle and owned McLaren sports cars and a Lamborghini — and even rented a plush waterfront home for $45,000 a month.
Tech led the stock market lower Tuesday, with major benchmarks weakening in the last hour. Berkshire Hathaway's Warren Buffett made $450 million on Occidental Petroleum after a Cowen upgrade. Berkshire added more shares in March.
Viking said Tuesday recipients of its potential obesity treatment lost up to 18 pounds, and VKTX stock launched to a five-year high.
Cathie Wood is all about disruption, which is why she laments what is happening to the Nasdaq. The Ark Invest financial guru has repeatedly called out the Nasdaq for no longer being the disruptive force it was envisioned to be, and Wood believes that the reason the major indices have become more risk averse is the tech and telecom bubble from the late 90s.
A major real estate investment trust (REIT) has lost more than half its value since its early August 2022 highs. Medical Properties Trust Inc. (NYSE: MPW) this week is making new 52-week lows as the months-long downward slide shows no sign of stopping. The REIT is suffering, along with many others in the sector, from investors dumping shares as the banking crisis remains front-page news and the Federal Reserve keeps raising interest rates. Lower expectations for a pivot – where rates begin to go
An Israeli cell therapy company with a U.S. headquarters in Boston is laying off nearly one-fifth of its staff as it puts three drug programs aside.
Commercial real estate debt and mortgages are a 'serious' threat to the economy, warns the serial entrepreneur and billionaire.
Micron reports Q2 FY 2023 results on March 28. Analysts expect the widest-ever net losses and revenue less than half what it was a year earlier.
Investors need to pay close attention to First Republic (FRC) stock based on the movements in the options market lately.
This year started with a strong rally in the markets, but the past month has seen the positive sentiments start to sputter. The failure of Silicon Valley Bank started fears of a contagion and consequent bank runs, which were only partially offset by Federal regulatory actions. But there’s a growing consensus that it was the Federal actions that set the conditions for the bank crisis, when the central bank raised interest rates to fight inflation. Now, investors are trying to cope with the fallou
High-yield savings accounts are offering big rates and low risk, but advisors say there are tradeoffs to consider.
CytomX Therapeutics Inc (NASDAQ: CTMX) will weigh its options for CX-2029, a CD71-directed antibody-drug conjugate, after AbbVie Inc (NYSE: ABBV) decided not to advance the drug into additional studies. CytomX and AbbVie have also concluded their research activities under a 2016 Discovery License and Collaboration Agreement. AbbVie paid $30 million upfront in 2016 to ink the deal and another $15 million in milestones in 2017 for the start of toxicology studies. Related: CytomX Shares Move Higher
Home prices in January saw the smallest gain since December 2019, according to S&P CoreLogic Case-Shiller.